ES489565A0 - Procedimiento para la obtencion de nuevos peptidos del tipo somatostatina - Google Patents

Procedimiento para la obtencion de nuevos peptidos del tipo somatostatina

Info

Publication number
ES489565A0
ES489565A0 ES489565A ES489565A ES489565A0 ES 489565 A0 ES489565 A0 ES 489565A0 ES 489565 A ES489565 A ES 489565A ES 489565 A ES489565 A ES 489565A ES 489565 A0 ES489565 A0 ES 489565A0
Authority
ES
Spain
Prior art keywords
somatostatin
radical
trp
somatostatine
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES489565A
Other languages
English (en)
Other versions
ES8103028A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES8103028A1 publication Critical patent/ES8103028A1/es
Publication of ES489565A0 publication Critical patent/ES489565A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/065—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for hydroxy functions, not being part of carboxy functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
ES489565A 1979-03-16 1980-03-14 Procedimiento para la obtencion de nuevos peptidos del tipo somatostatina Granted ES489565A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH250679 1979-03-16

Publications (2)

Publication Number Publication Date
ES8103028A1 ES8103028A1 (es) 1981-02-16
ES489565A0 true ES489565A0 (es) 1981-02-16

Family

ID=4235326

Family Applications (1)

Application Number Title Priority Date Filing Date
ES489565A Granted ES489565A0 (es) 1979-03-16 1980-03-14 Procedimiento para la obtencion de nuevos peptidos del tipo somatostatina

Country Status (17)

Country Link
US (1) US4316890A (es)
EP (1) EP0017760B1 (es)
JP (1) JPS55124748A (es)
KR (1) KR830001872A (es)
AT (1) ATE3283T1 (es)
AU (1) AU5646280A (es)
CA (1) CA1140117A (es)
DD (1) DD151059A5 (es)
DE (1) DE3063028D1 (es)
ES (1) ES489565A0 (es)
FI (1) FI800795A (es)
GR (1) GR67655B (es)
IL (1) IL59620A (es)
NO (1) NO800743L (es)
NZ (1) NZ193129A (es)
PT (1) PT70951A (es)
ZA (1) ZA801520B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
AU6770794A (en) * 1993-04-23 1994-11-21 Herbert J. Evans Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
ES2216290T3 (es) * 1997-05-13 2004-10-16 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Somatostatina y agonistas de la somatostatina para el tratamiento de insensibilidad a la insulina y de sindrome x.
WO1998051330A1 (en) * 1997-05-13 1998-11-19 Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) Method and compositions for treating hyperlipidemia and other conditions
CA2290592A1 (en) * 1997-05-13 1998-11-19 Michael Anthony Cawthorne Somatostatin and somatostatin agonists for decreasing body weight
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
RU2277539C2 (ru) 2001-06-08 2006-06-10 Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик С.А.С. Химерные аналоги соматостатина-дофамина
EP2161037A3 (en) 2003-04-22 2010-05-26 Ipsen Pharma Camptothecin-Somatostatin conjugates
JP5799397B2 (ja) 2008-06-12 2015-10-28 イプセン・バイオイノベーション・リミテッドＩｐｓｅｎ Ｂｉｏｉｎｎｏｖａｔｉｏｎ Ｌｉｍｉｔｅｄ 癌の抑制
WO2009150469A2 (en) 2008-06-12 2009-12-17 Syntaxin Limited Suppression of neuroendocrine diseases
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
JP6869720B2 (ja) 2013-06-13 2021-05-12 アンチセンス セラピューティクス リミテッド 併用療法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4020157A (en) * 1975-07-08 1977-04-26 Ayerst Mckenna And Harrison Ltd. Shortened analogs of somatostatin
US4372884A (en) * 1975-08-06 1983-02-08 The Salk Institute For Biological Studies Pharmaceutically active peptides
NL7607987A (nl) * 1975-08-08 1977-02-10 Merck & Co Inc Werkwijze voor het bereiden van peptiden.
US4122077A (en) * 1976-12-17 1978-10-24 American Home Products Corporation Somatostatin analogs
US4098782A (en) * 1977-03-14 1978-07-04 American Home Products Corporation (His5)-somatostatin and analogues thereof
US4115554A (en) * 1977-08-29 1978-09-19 Merck & Co., Inc. Somatostatin analogs
GB2019411B (en) * 1978-04-24 1982-06-16 American Home Prod Peptides related to somatostatin

Also Published As

Publication number Publication date
IL59620A (en) 1983-07-31
DD151059A5 (de) 1981-09-30
FI800795A (fi) 1980-09-17
IL59620A0 (en) 1980-06-30
ATE3283T1 (de) 1983-05-15
ES8103028A1 (es) 1981-02-16
EP0017760A1 (de) 1980-10-29
AU5646280A (en) 1980-09-18
EP0017760B1 (de) 1983-05-11
NO800743L (no) 1980-09-17
US4316890A (en) 1982-02-23
CA1140117A (en) 1983-01-25
GR67655B (es) 1981-09-02
PT70951A (en) 1980-04-01
NZ193129A (en) 1982-06-29
ZA801520B (en) 1981-03-25
KR830001872A (ko) 1983-05-19
JPS55124748A (en) 1980-09-26
DE3063028D1 (en) 1983-06-16

Similar Documents

Publication Publication Date Title
ES489565A0 (es) Procedimiento para la obtencion de nuevos peptidos del tipo somatostatina
DE3169160D1 (en) Amino-acids derivatives and their therapeutic use
ES8104993A1 (es) Un procedimiento para preparar compuestos aromaticos susti- tuidos
NZ191867A (en) N1,n1,2,3,4,5,6-substituted-1-piperazine-carboxamides and carbothioamides
ES536499A0 (es) Un procedimiento para la preparacion de nuevas 2-amino-5-hidroxi-4-metilpirimidinas.
JPS5564587A (en) Pyrimidoo*6*11a**isoquinolinee44one compound and its manufacture
FR2446838A1 (fr) Derives peptidiques d'acides phosphoniques
ES2054732T3 (es) Un procedimiento para preparar un derivado peptidico.
ES554305A0 (es) Procedimiento para la fabricacion de derivados quinolilglicinamidas
DE69012901T2 (de) Hämoregulierende Peptide.
ES2058176T3 (es) Un procedimiento para preparar un derivado peptidico.
FR2358384A1 (fr) Peptides psychopharmacologiquement actifs et derives de ces peptides
CH614433A5 (en) Use of diaryloxytriazolyl-O,N-acetals and their salts for controlling fungi
DE3568424D1 (en) Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension
DE69132084T2 (de) Isolierte metallopolypeptide, zusammensetzungen und syntheseverfahren
JPS5583758A (en) Novel 3*44diazaabicyclo*4*1*0*heptenee*2**onee *5**its manufacture and medicine containing it
FR2374027A1 (fr) Utilisation d'esters alcoxymethyliques d'acides carboxyliques pour l'amelioration de la structure de chevelures endommagees
ATE3146T1 (de) Neue 1-aryloxy-3-alkylamino-2-propanole und verfahren zu ihrer herstellung.
ATE59041T1 (de) Hexahydropyrrolo(2,1-a)isochinolinderivate.
ES2108017T3 (es) Uso de compuestos de benzodiazepina para la preparacion de composiciones farmaceuticas para el tratamiento de trastornos del snc relacionados con aminoacidos excitatorios.
DE3663947D1 (en) New indole derivatives, the production and uses thereof
FR2361335A1 (fr) 4-(3-(amino substitue)-2-hydroxypropoxy) - 5,6,7,8 - tetrahydro - 1,6,7 - naphtalenetriol
SE8604838L (sv) Farmaceutiska kompositioner
US5162542A (en) Substituted pyrazoline derivatives
ES528460A0 (es) Procedimiento de preparacion de nuevos deridados de alfa-etibenzol con un grupo amino propanolico sustituido y sus sales de adicion acidas y amonicas cuaternarias.